Converting evidence to practice: A guide for the clinical application of MRI for the screening and management of breast cancer

European Journal of Cancer

Volumn 44, Issue 18, 2008, Pages 2742-2752

  Zakhireh, Jennifer ^a   Gomez, Rachel ^a   Esserman, Laura ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer; Breast cancer staging; Breast magnetic resonance imaging (MRI); Screening

Indexed keywords

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER INVASION; CANCER PATIENT; CANCER RISK; CANCER SCREENING; CANCER STAGING; CARCINOMA IN SITU; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; EVIDENCE BASED MEDICINE; GENE MUTATION; HUMAN; LUNG CARCINOMA; LYMPH NODE METASTASIS; MAMMOGRAPHY; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PAGET NIPPLE DISEASE; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SURGICAL TECHNIQUE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MASS SCREENING; MASTECTOMY, SUBCUTANEOUS; NEOADJUVANT THERAPY; NEOPLASM STAGING;

EID: 56949093243     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.09.008     Document Type: Article

References (70)

1. Heywang S.H., Hahn D., Schmidt H., et al. MR imaging of the breast using gadolinium-DTPA. J Comput Assist Tomogr 10 2 (1986) 199-204
2. Heywang S.H., Wolf A., Pruss E., Hilbertz T., Eiermann W., and Permanetter W. MR imaging of the breast with Gd-DTPA: use and limitations. Radiology 171 1 (1989) 95-103
3. Kaiser W.A., and Zeitler E. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations. Radiology 170 3 Pt 1 (1989) 681-686
4. Revel D., Brasch R.C., Paajanen H., et al. Gd-DTPA contrast enhancement and tissue differentiation in MR imaging of experimental breast carcinoma. Radiology 158 2 (1986) 319-323
5. Pierce W.B., Harms S.E., Flamig D.P., Griffey R.H., Evans W.P., and Hagans J.E. Three-dimensional gadolinium-enhanced MR imaging of the breast: pulse sequence with fat suppression and magnetization transfer contrast. Work in progress. Radiology 181 3 (1991) 757-763
6. Stack J.P., Redmond O.M., Codd M.B., Dervan P.A., and Ennis J.T. Breast disease: tissue characterization with Gd-DTPA enhancement profiles. Radiology 174 2 (1990) 491-494
7. Bhattacharyya M., Ryan D., Carpenter R., Vinnicombe S., and Gallagher C.J. Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancer. Brit J Cancer 98 2 (2008) 289-293
8. Peters N.H., Borel Rinkes I.H., Zuithoff N.P., Mali W.P., Moons K.G., and Peeters P.H. Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology 246 1 (2008) 116-124
9. Hrung J.M., Sonnad S.S., Schwartz J.S., and Langlotz C.P. Accuracy of MR imaging in the work-up of suspicious breast lesions: a diagnostic meta-analysis. Acad Radiol 6 7 (1999) 387-397
10. Hoogerbrugge N., Kamm Y.J., Bult P., et al. The impact of a false-positive MRI on the choice for mastectomy in BRCA mutation carriers is limited. Ann Oncol (2007)
11. Harms S.E., Flamig D.P., Hesley K.L., et al. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 187 2 (1993) 493-501
12. Skaane P. The additional value of US to mammography in the diagnosis of breast cancer. A prospective study. Acta Radiol 40 5 (1999) 486-490
13. Bjurstam N., Bjorneld L., Warwick J., et al. The Gothenburg breast screening trial. Cancer 97 10 (2003) 2387-2396
14. Nystrom L., Andersson I., Bjurstam N., Frisell J., Nordenskjold B., and Rutqvist L.E. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 359 9310 (2002) 909-919
15. Nystrom L., Rutqvist L.E., Wall S., et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 341 8851 (1993) 973-978
16. Rijnsburger A.J., van Oortmarssen G.J., Boer R., et al. Mammography benefit in the Canadian National Breast Screening Study-2: a model evaluation. Int J Cancer 110 5 (2004) 756-762
17. Shapiro S. Periodic screening for breast cancer: the HIP Randomized Controlled Trial. Health Insurance Plan. J Natl Cancer Inst Monogr 22 (1997) 27-30
18. Andersson I., Aspegren K., Janzon L., et al. Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial. BMJ 297 6654 (1988) 943-948
19. Tabar L., Fagerberg C.J., Gad A., et al. Reduction in mortality from breast cancer after mass screening with mammography Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1 8433 (1985) 829-832
20. Alexander F.E., Anderson T.J., Brown H.K., et al. 14 Years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet 353 9168 (1999) 1903-1908
21. Ernster V.L., Ballard-Barbash R., Barlow W.E., et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 94 20 (2002) 1546-1554
22. Carney P.A., Miglioretti D.L., Yankaskas B.C., et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 138 3 (2003) 168-175
23. Saslow D., Boetes C., Burke W., et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57 2 (2007) 75-89
24. Warner E., Plewes D.B., Hill K.A., et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292 11 (2004) 1317-1325
25. Kriege M., Brekelmans C.T., Boetes C., et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. New Engl J Med 351 5 (2004) 427-437
26. Arpino G., Laucirica R., and Elledge R.M. Premalignant and in situ breast disease: biology and clinical implications. Ann Intern Med 143 6 (2005) 446-457
27. Dupont W.D., and Page D.L. Risk factors for breast cancer in women with proliferative breast disease. New Engl J Med 312 3 (1985) 146-151
28. Page D.L., Dupont W.D., Rogers L.W., and Rados M.S. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 55 11 (1985) 2698-2708
29. Hartmann L.C., Sellers T.A., Frost M.H., et al. Benign breast disease and the risk of breast cancer. New Engl J Med 353 3 (2005) 229-237
30. Boyd N.F., Byng J.W., Jong R.A., et al. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 87 9 (1995) 670-675
31. Byrne C., Schairer C., Wolfe J., et al. Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 87 21 (1995) 1622-1629
32. Kerlikowske K. The mammogram that cried Wolfe. New Engl J Med 356 3 (2007) 297-300
33. Ursin G., Hovanessian-Larsen L., Parisky Y.R., Pike M.C., and Wu A.H. Greatly increased occurrence of breast cancers in areas of mammographically dense tissue. Breast Cancer Res 7 5 (2005) R605-R608
34. Gail M.H., Brinton L.A., Byar D.P., et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81 24 (1989) 1879-1886
35. Tice J.A., Cummings S.R., Ziv E., and Kerlikowske K. Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population. Breast Cancer Res Treat 94 2 (2005) 115-122
36. Plevritis S.K., Kurian A.W., Sigal B.M., et al. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. JAMA 295 20 (2006) 2374-2384
37. Schnall M.D., Blume J., Bluemke D.A., et al. MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883. J Surg Oncol 92 1 (2005) 32-38
38. Kuhl C.K., Schrading S., Bieling H.B., et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet 370 9586 (2007) 485-492
39. Hrung J.M., Langlotz C.P., Orel S.G., Fox K.R., Schnall M.D., and Schwartz J.S. Cost-effectiveness of MR imaging and core-needle biopsy in the preoperative work-up of suspicious breast lesions. Radiology 213 1 (1999) 39-49
40. Esserman L., Hylton N., Yassa L., Barclay J., Frankel S., and Sickles E. Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol 17 1 (1999) 110-119
41. Mann R.M., Veltman J., Barentsz J.O., Wobbes T., Blickman J.G., and Boetes C. The value of MRI compared to mammography in the assessment of tumour extent in invasive lobular carcinoma of the breast. Eur J Surg Oncol (2007)
42. Caramella T., Chapellier C., Ettore F., Raoust I., Chamorey E., and Balu-Maestro C. Value of MRI in the surgical planning of invasive lobular breast carcinoma: a prospective and a retrospective study of 57 cases: comparison with physical examination, conventional imaging, and histology. Clin Imaging 31 3 (2007) 155-161
43. Kim do Y., Moon W.K., Cho N., et al. MRI of the breast for the detection and assessment of the size of ductal carcinoma in situ. Korean J Radiol 8 1 (2007) 32-39
44. Hwang E.S., and Esserman L. Neoadjuvant hormonal therapy for ductal carcinoma in situ: trial design and preliminary results. Ann Surg Oncol 11 1 Suppl (2004) 37S-43S
45. Jackson B., Scott-Conner C., and Moulder J. Axillary metastasis from occult breast carcinoma: diagnosis and management. Am Surg 61 5 (1995) 431-434
46. Fortunato L., Sorrento J.J., Golub R.A., and Cantu R. Occult breast cancer. A case report and review of the literature. New York State J Med 92 12 (1992) 555-557
47. Olson Jr. J.A., Morris E.A., Van Zee K.J., Linehan D.C., and Borgen P.I. Magnetic resonance imaging facilitates breast conservation for occult breast cancer. Ann Surg Oncol 7 6 (2000) 411-415
48. Kothari A.S., Beechey-Newman N., Hamed H., et al. Paget disease of the nipple: a multifocal manifestation of higher-risk disease. Cancer 95 1 (2002) 1-7
49. Marshall J.K., Griffith K.A., Haffty B.G., et al. Conservative management of Paget disease of the breast with radiotherapy: 10- and 15-year results. Cancer 97 9 (2003) 2142-2149
50. Frei K.A., Bonel H.M., Pelte M.F., Hylton N.M., and Kinkel K. Paget disease of the breast: findings at magnetic resonance imaging and histopathologic correlation. Invest Radiol 40 6 (2005) 363-367
51. Lehman C.D., Gatsonis C., Kuhl C.K., et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. New Engl J Med 356 13 (2007) 1295-1303
52. Liberman L., Morris E.A., Kim C.M., et al. MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR Am J Roentgenol 180 2 (2003) 333-341
53. Yeh E., Slanetz P., Kopans D.B., et al. Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR Am J Roentgenol 184 3 (2005) 868-877
54. Chagpar A.B., Middleton L.P., Sahin A.A., et al. Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy. Ann Surg 243 2 (2006) 257-264
55. Londero V., Bazzocchi M., Del Frate C., et al. Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy. Eur Radiol 14 8 (2004) 1371-1379
56. Partridge S.C., Gibbs J.E., Lu Y., Esserman L.J., Sudilovsky D., and Hylton N.M. Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR Am J Roentgenol 179 5 (2002) 1193-1199
57. Hylton N. Magnetic resonance imaging of the breast: opportunities to improve breast cancer management. J Clin Oncol 23 8 (2005) 1678-1684
58. Hylton N. MR imaging for assessment of breast cancer response to neoadjuvant chemotherapy. Magn Reson Imaging Clin North America 14 3 (2006) 383-389 vii
59. Partridge S.C., Gibbs J.E., Lu Y., et al. MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. AJR Am J Roentgenol 184 6 (2005) 1774-1781
60. Gomez R, Hylton N, Madhavan S, et al. Preliminary results from I-SPY trial: tumor patterns on pre-treatment MRI predict breast conservation therapy eligibility. In: Abstract #2024 San Antonio breast cancer symposium, San Antonio, TX, 2007.
61. Wijayanayagam A., Kumar A.S., Foster R.D., and Esserman L.J. Optimizing the total skin-sparing mastectomy. Arch Surg 143 1 (2008) 38-45 [discussion 45]
62. Chattopadhyay R, Radzio A, Kumar AS, et al. Optimizing surgical technique for total skin-sparing mastectomy. In: Abstract #5096 San Antonio breast cancer symposium, San Antonio, TX, 2007.
63. Gerber B., Krause A., Reimer T., et al. Skin-sparing mastectomy with conservation of the nipple-areola complex and autologous reconstruction is an oncologically safe procedure. Ann Surg 238 1 (2003) 120-127
64. Caruso F., Ferrara M., Castiglione G., et al. Nipple sparing subcutaneous mastectomy: sixty-six months follow-up. Eur J Surg Oncol 32 9 (2006) 937-940
65. Sacchini V., Pinotti J.A., Barros A.C., et al. Nipple-sparing mastectomy for breast cancer and risk reduction: oncologic or technical problem?. J Am Coll Surg 203 5 (2006) 704-714
66. Heywang-Kobrunner S.H., Bick U., Bradley Jr. W.G., et al. International investigation of breast MRI: results of a multicentre study (11 sites) concerning diagnostic parameters for contrast-enhanced MRI based on 519 histopathologically correlated lesions. Eur Radiol 11 4 (2001) 531-546
67. Orel S.G., and Schnall M.D. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 220 1 (2001) 13-30
68. Liu P.F., Debatin J.F., Caduff R.F., Kacl G., Garzoli E., and Krestin G.P. Improved diagnostic accuracy in dynamic contrast enhanced MRI of the breast by combined quantitative and qualitative analysis. Brit J Radiol 71 845 (1998) 501-509
69. Kumar A.S., Chen D.F., Au A., et al. Biologic significance of false-positive magnetic resonance imaging enhancement in the setting of ductal carcinoma in situ. Am J Surg 192 4 (2006) 520-524
70. Hylton N, Carey L, De Michele A, et al. Characterizing the biology and response of locally advanced breast cancer in women undergoing neoadjuvant therapy; preliminary results from the I-SPY trial. In: Abstract #80 San Antonio breast cancer symposium, 2007.